*Cagri-Sema 5 MG each

*Cagri-Sema 5 MG each

Regular price $115.00 USD
Regular price $138.98 USD Sale price $115.00 USD
Sale Sold out

What is Cagrilintide  / GLP-1 Sema?

This dual-peptide formulation combines Cagrilintide, a long-acting amylin analog, with a GLP-1 S receptor agonist, creating a synergistic compound designed to support appetite suppression, gastric emptying delay, and metabolic regulation. This blend mimics and amplifies the body’s natural satiety signals, making it a strong research candidate in the field of obesity, type 2 diabetes, and weight loss.

  • Cagrilintide works by activating amylin receptors in the brain, which regulate meal size and fullness.
  • GLP-1 Sema analogs enhance insulin secretion, reduce glucagon, and delay gastric emptying. Together, they create a powerful combination that supports a multi-pathway approach to appetite control and metabolic health.

 

What Are the Effects of Cagrilintide  / GLP-1 Sema?

Appetite Suppression and Satiety Enhancement

Cagrilintide and GLP-1 Sema both promote a prolonged feeling of fullness by acting on the hypothalamus and gastrointestinal tract. This effect supports reduced caloric intake and long-term weight management.

Improved Glycemic Control

GLP-1 Sema analogs have been shown to increase insulin secretion in a glucose-dependent manner, while reducing glucagon release and improving insulin sensitivity—making this blend highly relevant for type 2 diabetes research.

Delay in Gastric Emptying

Both peptides slow the rate of gastric emptying, helping control postprandial glucose spikes and increasing the duration of satiety after meals.

Synergistic Weight Loss Potential

Clinical studies have shown that combining amylin and GLP-1 Sema receptor agonists produces superior weight loss results compared to either peptide alone, due to their complementary mechanisms.

 

Chemical Structure of Cagrilintide / GLP-1 Sema

This blend contains two distinct peptides:

  • Cagrilintide: Modified amylin analog with prolonged half-life via fatty acid acylation.
  • GLP-1 S analog: Glucagon-like peptide-1 receptor agonist with extended duration.

These peptides act through different receptor systems but complement each other by targeting overlapping metabolic and gastrointestinal pathways.

View full details